Why the study?
Does metabolic syndrome increase the risk of in-hospital heart failure and mortality in patients with acute coronary syndrome?
Does metabolic syndrome increase the risk of in-hospital heart failure and mortality in patients with acute coronary syndrome?
Metabolic syndrome is highly prevalent among ACS patients in Oman and is independently associated with significantly increased risks of in-hospital heart failure and mortality.
Answers are grounded in this paper and cite their sources.
Supports MetS assessment in ACS for in-hospital risk awareness; leaves open whether targeted interventions improve outcomes.
We evaluated in-hospital outcomes of acute coronary syndrome (ACS) patients with metabolic syndrome (MetS) in Oman. We analyzed the records of 1392 patients admitted with a diagnosis of ACS as part of the Gulf Registry of Acute Coronary Events. The prevalence of MetS among patients with ACS was 66%, with female preponderance (80% vs 57%; P < .001). MetS was associated with several characteristics including diabetes (45% vs 19%; P < .001), hyperlipidemia (40% vs 23%; P < .001), hypertension (62% vs 34%; P < .001), renal impairment (9.3% vs 3.4%; P < .001), Killip score > II (13% vs 8%; P = .004), and non-ST segment elevation myocardial infarction (78% vs 68%; P < .001). After multivariate adjustment, MetS was associated with higher risk of in-hospital heart failure (odds ratio [OR], 1.37; 95% CI: 1.03-1.81; P = .028) and mortality (OR, 4.42; 95% CI: 1.25-15.5; P = .020). Prevalence of MetS among patients with ACS in Oman is high. MetS was associated with higher in-hospital heart failure and mortality.
No takes yet. Share an insight, caveat, or question.
Al‐Rasadi et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: